Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.
2 reports, 2 independent
Updated Oct 8
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Makary, a former FDA official, spoke with Focus regarding FDA matters.1 source
FDA Commissioner Marty Makary advocates for psychedelic therapies.1 source
Keep exploring
The entities involved
- FDA
-
Marty Makary
American surgeon and FDA Commissioner
Nothing else this week.
-
Robert F. Kennedy Jr.
American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)
Related events
- Cleveland Clinic and Harvard Medical School provided input on psychedelic drug regulation.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
- Presley Gerber posted about Ibogaine on Instagram while Marty Makary advised the FDA on drug approval potential amid an executive order fast-tracking psychedelic research.
- FDA hosts a public meeting at White Oak as it begins rethinking drug development under Donald Trump's influence.
- The FDA has issued guidance outlining the clinical trial requirements for new drug classes, including psychedelic drugs.